Identification of antigenic peptides recognized by cytolytic T lymphocytes (CTL) is a prerequisite for the development of targeted cancer immunotherapy approaches. This chapter provides a global approach for the identification of peptides recognized by CTL. It implies the identification of the HLA molecule presenting the peptide as well as the design and screening of a cDNA library derived from the tumor cells. Methods used for the identification of spliced peptides on tumors are also described.
CITATION STYLE
Vigneron, N., Stroobant, V., Ma, W., Michaux, A., & Van den Eynde, B. J. (2019). Identifying antigens recognized by cytolytic T lymphocytes on tumors. In Methods in Molecular Biology (Vol. 1988, pp. 159–186). Humana Press Inc. https://doi.org/10.1007/978-1-4939-9450-2_13
Mendeley helps you to discover research relevant for your work.